1. Among adult patients with migraine headaches, the use of a prescribed digital health app did not reduce the number of migraine days compared with a control app consisting of only migraine diary ...

Dear Abby: I realized what’s triggering my migraines, and now I have a new problem Plus: If I mention my new friend, my best friend shuts down ...

Explore the link between migraine and hearing loss. Discover what the research says and which symptoms to look for.

Tonix Pharmaceuticals has announced the publication of its Phase 3 RESILIENT trial results for TNX-102 SL, a sublingual formulation of cyclobenzaprine for treating fibromyalgia. The data shows ...

“The RESILIENT data that are now published on-line in Pain Medicine underscores the therapeutic promise of TNX-102 SL, our non-opioid, centrally-acting analgesic in development for reducing ...

A major accreditation application deadline looms on Aug. 1 if the planned BYU School of Medicine wants to reach its aggressive goal for admitting its first students.

Primary care clinicians focus on acute migraine management, despite the chronic nature of this neurological disease.

Intravenous thrombolysis remains a standard treatment for acute ischemic stroke within 4.5 hours after onset. Vascular reocclusion may occur after intravenous thrombolysis and may be preventable wi ...

Calcitonin gene-related peptide (CGRP) receptor antagonists have demonstrated clinical efficacy in the treatment of migraine. In this study, we performed surface plasmon resonance-based fragment ...

medication overuse headaches from using migraine medicine for 10 or more days each month. If your headaches get worse, call your provider. serotonin syndrome, a rare but serious problem that can ...

Tonix Pharmaceuticals has published a study demonstrating that the combination of mTNX-1700, a fusion protein targeting neutrophil-mediated immune evasion, with an anti-PD1 antibody significantly ...